Key Results of International Randomized Open-Label Clinical Study of BCD-020 (rituximab biosimilar candidate) in Patients with B-Cell Non-Hodgkin’s Lymphoma

Autor: Kaplanov, Kamil *, Zaritskiy, Andrey *, Alexeev, Sergey *, Volodicheva, Elena *, Loginov, Alexander *, Orlova, Rashida *, Dvornichenko, Victoria *, Kosinova, Marina *, Serduk, Olga *, Milovanov, Vladimir *, Myasnikov, Alexander *, Patil, Shekar *, Rangarajan, Bharath *, Rajappa, Senthil Jagannathan *, Jain, Minish *, Nirni, Sharanabasappa *, Deka, Akhil *, Rekhtman, Grigoriy B *, Kryachok, Iryna, Maslyak, Zvenyslava *, Chernyaeva, Ekaterina *, Ivanov, Roman *, Isaev, Alexander *
Zdroj: In Blood 6 December 2014 124(21):5467-5467
Databáze: ScienceDirect